Abstract:Cytotoxic T lymphocytes (CTL) are a major factor in the control of HIV replication. CTL arise in acute infection, causing escape mutations to spread rapidly through the population of infected cells. As a result, the virus develops partial resistance to the immune response. The factors controlling the order of mutating epitope sites are currently unknown and would provide a valuable tool for predicting conserved epitopes. In this work, we adapt a well-established mathematical model of HIV evolution under dynamical selection pressure from multiple CTL clones to include partial impairment of CTL recognition, [Formula: see text], as well as cost to viral replication, [Formula: see text]. The process of escape is described in terms of the cost-benefit tradeoff of escape mutations and predicts a trajectory in the cost-benefit plane connecting sequentially escaped sites, which moves from high recognition loss/low fitness cost to low recognition loss/high fitness cost and has a larger slope for early escapes than for late escapes. The slope of the trajectory offers an interpretation of positive correlation between fitness costs and HLA binding impairment to HLA-A molecules and a protective subset of HLA-B molecules that was observed for clinically relevant escape mutations in the Pol gene. We estimate the value of [Formula: see text] from published experimental studies to be in the range (0.01-0.86) and show that the assumption of complete recognition loss ([Formula: see text]) leads to an overestimate of mutation cost. Our analysis offers a consistent interpretation of the commonly observed pattern of escape, in which several escape mutations are observed transiently in an epitope. This non-nested pattern is a combined effect of temporal changes in selection pressure and partial recognition loss. We conclude that partial recognition loss is as important as fitness loss for predicting the order of escapes and, ultimately, for predicting conserved epitopes that can be targeted by vaccines.

Evolutionary Game Theoretic Strategy for Optimal Drug Delivery to Influence Selection Pressure in Treatment of HIV-1

Intrapatient Evolutionary Dynamics in an Individual Infected with HIV-1 CRF01_AE Who Experienced Periods of Treatment Failure

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

[[Research Progress in Escape Mutations of the Human Immunodeficiency Virus under Pressure of HLA-Restricted Cytotoxic T Lymphocytes].

A mathematical model for HIV dynamics with multiple infections: implications for immune escape

Computational Inference Methods for HIV-1 Selective Sweeps Shaped by Early Cytotoxic T-Lymphocyte Response

Evolutionary Dynamics Optimal Research-Oriented Tumor Immunity Architecture

Human immunodeficiency virus (HIV) dynamics in secondary lymphoid tissues and the evolution of cytotoxic T lymphocyte (CTL) escape mutants

The Route of HIV Escape from Immune Response Targeting Multiple Sites Is Determined by the Cost-Benefit Tradeoff of Escape Mutations

A Physical Theory of the Competition that Allows HIV to Escape from the Immune System

Analysis of a Stochastic Predator-Prey Model with Applications to Intrahost HIV Genetic Diversity

Transmission dynamics and optimal control strategies in a multi-pathways delayed HIV infection model with multi-drug therapy

Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes

Piecewise immunosuppressive infection model with viral logistic growth and effector cell-guided therapy

Exploiting evolution to treat drug resistance: combination therapy and the double bind

A binary trait model reveals the fitness effects of HIV-1 escape from T cell responses

Optimal Control Strategies and Sensitivity Analysis of an HIV/AIDS-Resistant Model with Behavior Change

Viral evolution under the pressure of an adaptive immune system - optimal mutation rates for viral escape

Theoretical understanding of evolutionary dosing following tumor dynamics

Evolution and transmission of stable CTL escape mutations in HIV infection

Hybrid Spreading Mechanisms and T Cell Activation Shape the Dynamics of HIV-1 Infection